SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-030595
Filing Date
2015-05-14
Accepted
2015-05-14 14:22:32
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v409314_10q.htm 10-Q 444846
2 EXHIBIT 10.1 v409314_ex10-1.htm EX-10.1 47621
3 EXHIBIT 31.1 v409314_ex31-1.htm EX-31.1 9480
4 EXHIBIT 31.2 v409314_ex31-2.htm EX-31.2 9603
5 EXHIBIT 32.1 v409314_ex32-1.htm EX-32.1 4056
6 EXHIBIT 32.2 v409314_ex32-2.htm EX-32.2 4171
  Complete submission text file 0001144204-15-030595.txt   3362016

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT svon-20150331.xml EX-101.INS 373589
8 XBRL TAXONOMY EXTENSION SCHEMA svon-20150331.xsd EX-101.SCH 35589
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svon-20150331_cal.xml EX-101.CAL 25722
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svon-20150331_def.xml EX-101.DEF 193062
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE svon-20150331_lab.xml EX-101.LAB 267018
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svon-20150331_pre.xml EX-101.PRE 221136
Mailing Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121
Business Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121 908-864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 15862041
SIC: 8731 Services-Commercial Physical & Biological Research